CHC

  • About Us
  • News
  • Coming Up
  • Resources
  • Contact Us
  • Search

Coalition Defends Use of Rx Data

July 13, 2009

Read the Coalition’s Amici Brief, submitted to appeals court, defending marketing use of prescription data and asserting First Amendment rights.

how to enlarge penile length naturally

View the Brief

Posted in Courts/First Amendment, General

Post navigation

4A's Urges President and Congress to End Efforts to Remove Drug Ad Deductibility
FDA Draft Guidance: Potentially a Significant Danger

Categories

  • CHC News
  • Courts/First Amendment
  • Data Privacy
  • Drug Pricing
  • DTC Advertising
  • General
  • Legislative
  • Off-label Promotion
  • Point of Care
  • Regulatory/FDA
  • Uncategorized
  • Washington Focus

Recent Posts

  • OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading
  • HHS Formally Withdraws SUNSET Final Rule
  • OPDP Reorg, Outreach Efforts Designed to Improve Relationship with Industry
  • OPDP to Study Risk/Benefit Tradeoff Decisions Made by Consumers, Physicians
  • Only 6 Percent of Novel Drug Approvals in 2021 Involved Advisory Committee Meetings

Tags

ad tax Advertising Coalition CDER CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media free speech gifts to physicians HHS John Kamp Jon Bigelow kamp Kate Rawson legislation litigation marketing off-label off-label communication omission of risk OPDP OPDP enforcement PhRMA regulation Risk Information rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines
CHC

Smart Brief
© 2021 Coalition for Healthcare Communication. All rights reserved.